arrow
G

Glen Hazlewood

University of Calgary
H指数:34
被引数:6,877

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Development of a single-item patient-reported measure of treatment side-effect burden in clinical trials of rheumatic and musculoskeletal diseases using stakeholder input and large language model refinement

基于利益相关者输入和大语言模型精炼,开发一种用于风湿与肌肉骨骼疾病临床试验的单项目患者报告的治疗副作用负担测量方法

2026-06-010
OAAI
Validity and Utility of a Single-Item Patient-Reported Measure of Treatment-Related Bother in Rheumatoid Arthritis: A Cross-Sectional OMERACT Study

类风湿关节炎治疗相关困扰的单项患者报告测量法的有效性与实用性:一项横断面OMERACT研究

2026-04-190
OAAI
A semi-automated approach facilitated the assessment of the certainty of evidence in a network meta-analysis: Part 1 – Direct comparisons

一种半自动化的方法促进了网络荟萃分析中证据确定性评估:第一部分——直接比较

2025-12-180
PREAI
A semi-automated approach facilitated the assessment of the certainty of evidence for in a network meta-analysis: Part 2 – Indirect and Mixed comparisons

一种半自动化的方法促进了网络Meta分析中证据确定性评估:第二部分——间接与混合比较

2025-12-160
PRE
Canadian Rheumatology Association/Canadian Research Group of Rheumatology in Immuno-Oncology Living Guidelines for Baseline Immunosuppression in Individuals With Preexisting Rheumatic Diseases Initiating Immune Checkpoint Inhibitors. Part 1: Arthritides

加拿大风湿病学协会/加拿大风湿病学免疫肿瘤学研究组关于在启动免疫检查点抑制剂治疗的患者中,对原有风湿性疾病患者进行基线免疫抑制的实用指南。第1部分:关节炎类疾病

2025-12-012
PRE
Canadian Rheumatology Association/Canadian Research Group of Rheumatology in Immuno-Oncology Living Guidelines for Baseline Immunosuppression in Individuals With Preexisting Rheumatic Diseases Initiating Immune Checkpoint Inhibitors. Part 2: Preexisting Systemic Autoimmune Rheumatic Diseases

加拿大风湿病学协会/加拿大风湿病学免疫肿瘤学研究组关于在免疫检查点抑制剂治疗开始前存在风湿性疾病患者基线免疫抑制的实用指南。第2部分:存在系统性自身免疫性风湿病。

2025-12-011
PRE
Thinking Outside the Joints: The Impact of Nonarticular Pain on Patient-Reported Outcomes in a Prospective Longitudinal Real-World Early Rheumatoid Arthritis Cohort

超越关节:非关节疼痛对前瞻性纵向真实世界早期类风湿关节炎队列患者报告结局的影响

2025-12-010
PRE
Corrigendum to GRADE guidance 39: using GRADE-ADOLOPMENT to adopt, adapt or create contextualized recommendations from source guidelines and evidence syntheses [Journal of Clinical Epidemiology 81 (2024) 111494]

勘误表:GRADE指南39:使用GRADE-ADOLOPMENT从源指南和证据综合中采纳、改编或创建情境化建议 [《临床流行病学杂志》81卷(2024年)第111494页]

2025-09-270
PRE
Higher comorbidities associated with less improvement in disease activity in early RA: results from CATCH cohort

早期类风湿关节炎(RA)中,较高的合并症与疾病活动度改善较少相关:CATCH队列研究的结果

2025-07-011
PRE
Standardizing health outcomes for people with rheumatoid arthritis receiving disease modifying drug therapy: A rapid review of patient-decision aids and preference studies to inform the development of OMERACT Health Outcome Descriptors

为接受改善病情药物疗法治疗的类风湿关节炎患者标准化健康结局:一项快速综述,旨在通过患者决策辅助工具和偏好研究,为OMERACT健康结局描述符的开发提供信息

2025-06-060
OAAI
Characterizing Nonarticular Pain at Early Rheumatoid Arthritis Diagnosis: Evolution Over the First Year of Treatment and Impact on Remission in a Prospective Real-World Early Rheumatoid Arthritis Cohort
2024-11-210
OAAI
Proactive therapeutic drug monitoring of biologic drugs in adult patients with inflammatory bowel disease, inflammatory arthritis, or psoriasis: a clinical practice guideline
2024-10-282
PRE
GRADE guidance 39: using GRADE-ADOLOPMENT to adopt, adapt or create contextualized recommendations from source guidelines and evidence syntheses

39年级指导: 使用GRADE-adoolopment从源指南和证据综合中采用,适应或创建情境化建议

2024-10-012
PRE